ELITE PHARMACEUTICALS's ticker is ELTP and the CUSIP is 28659T200. A total of 1 filers reported holding ELITE PHARMACEUTICALS in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $4,000 | -20.0% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $5,000 | +25.0% | 50,000 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $4,000 | +100.0% | 50,000 | 0.0% | 0.00% | +100.0% |
| Q2 2019 | $2,000 | -60.0% | 50,000 | 0.0% | 0.00% | -66.7% |
| Q1 2019 | $5,000 | +25.0% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $4,000 | -20.0% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $5,000 | 0.0% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $5,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Highlander Capital Management, LLC | 50,000 | $5,000 | 0.00% |